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Abstract   Extracorporeal membrane oxygenation (ECMO) is a rescue therapy for 
patients with cardio-respiratory failure which exposes the patient to the risk for in-
tracranial injury. We used a 12-channel optical topography system to monitor ce-
rebral oxygenation in a venoarterial (VA) ECMO patient during alterations in the 
ECMO flows. Changes in oxy-(HbO2), deoxy-(HHb) and total-(HbT) haemoglo-
bin concentrations were measured simultaneously with systemic and ECMO cir-
cuit parameters. Decreasing the flows resulted in a decrease in venous (SvO2) and 
arterial (SpO2) saturations. These were reflected in the haemoglobin data by a sig-
nificant increase in HHb of varying magnitude across the 12 channels and mod-
erate changes in HbO2 suggestive of cerebral arterial dilation to compensate for 
the lack of oxygen delivery. In the patient studied here ECMO flows appear to 
present a significant haemodynamic challenge to cerebral circulation.   
1 Introduction     
Extracorporeal membrane oxygenation (ECMO) is a life support system incorpo-
rating cardiopulmonary bypass in infants and children with intractable cardio-
respiratory failure. Establishing ECMO involves cannulation of major vessels in 
the neck–right common carotid artery (RCCA) and internal jugular vein (IJV). 
Maintaining and weaning from ECMO requires manipulation of ECMO flows, 
which can affect cerebral blood flow and potentially lead to neurologic complica-
tions. Reports show that about 28-52% of ECMO survivors show abnormal neuro-
imaging related both to pre-ECMO events and to the ECMO procedure itself [1]. 
Near infrared spectroscopy (NIRS) has the advantage of monitoring cerebral 
oxygenation non-invasively and continuously by the bedside. NIRS was used on 
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ECMO patients to study the effect of cannulation on cerebral oxygenation. Liga-
tion of RCCA was associated with a decrease in HbO2, an increase in HHb [2] and 
a decrease in tissue oxygen saturation (TOS) [3] while no changes were seen dur-
ing IJV ligation. Also, an increase in HbO2, a decrease in HHb and an increase in 
TOS was reported after ECMO was established compared to pre-cannulation val-
ues. In a previous study we used spectral analysis on HbO2 and identified vasomo-
tion, respiratory, cardiac and ECMO circuit roller pump oscillations in cerebral 
and peripheral circulation during ECMO flow changes [4].  To date, conventional 
NIRS uses single or dual channel systems with the optodes usually placed on the 
forehead of the patients providing information related to perfusion of only a small 
area of the anterior cerebrum and therefore do not allow evaluation of the status of 
the cerebral circulation and oxygenation in the extended cerebral regions.  
The aim of this study is to use optical topography (OT) to monitor multisite 
brain oxygenation responses during manipulations in the ECMO circuit flows. 
2 Methods     
In this pilot study OT data were obtained from a one-month-old veno-arterial 
(VA) ECMO patient undergoing changes in the ECMO circuit flows. Flow in the 
ECMO circuit was successively decreased by 10% from initial flow every 10-15 
minutes, down to 70% of the initial flow and it was then gradually brought back to 
initial flow. During this procedure ETG-100 OT system (Hitachi Medical Ltd.) 
was used to measure changes in HbO2, HHb and HbT (HbO2 + HHb) haemoglobin 
concentrations using the modified Beer-Lambert Law. A novel neonatal cap was 
designed and constructed to accommodate the optical fibres in a 3x3 array (inter-
optode distance = 3cm) utilizing spring-loaded optical fibre holders. The probe ar-
ray was positioned on the patient’s head with the middle optode corresponding to 
Cz of the 10-20 EEG electrode placement system [5]. This optode configuration 
allows for optical data to be collected from 12 channels distributed symmetrically 
around Cz and covering an area of 6x6 cm
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. Optical data collected at a sampling 
frequency of 5Hz were resampled at 1Hz and low pass filtered at 0.05Hz to re-
move physiological noise. For the conversion of the optical attenuation changes to 
chromophore concentration changes a differential pathlength factor (DPF) of 4.99 
was applied [6]. Multimodal data were collected synchronously with the optical 
data that included systemic parameters: arterial blood pressure (ABP), heart rate 
(HR), respiration rate (RR), end-tidal CO2, temperature and arterial saturation 
(SpO2); and ECMO circuit parameters: venous saturation (SvO2), arterial satura-
tion measured at the arterial cannula side (SaO2), haematocrit and ECMO flow. 
 Changes in HbO2, HHb and HbT between phase I [from baseline flow (100%) 
to minimum flow (70%)] and phase II [from 70% flow back to baseline flow] 
were calculated from the differences in mean values over a 60-s period just before 
changing the flow. The results were analysed using a paired t-test (p<0.05). 
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3 Results     
Figure 1 shows concentration changes in HbO2 (red), HHb (blue) and HbT (black) 
collected from the 12 channels during changes in ECMO flows. The channel con-
figuration is shown by the schematic at the top left of the figure. As annotated in 
the haemoglobin plots of channel 1, the vertical dotted lines represent the time at 
which a change in flow was induced so that each section in the plots corresponds 
to a specific flow. Sequential reduction in ECMO flows resulted in considerable 
increase in HHb and HbT in all 12 channels, with moderate increases seen in 
HbO2. Table 1 lists the responses in HHb, HbO2 and HbT during phase I and 
phase II.  The range in the change of HHb concentration during phase I was from 
9.7µM (channel 8) to 25.1µM (channel 10). Regional variations in cerebral oxy-
genation can be seen, particularly interhemispheric differences, e.g. comparing 
channel 10 (right parietal lobe) with channel 8 (left parietal lobe).  
The variation in HR, MAP, SpO2 and SvO2 during flow changes are shown in 
Figure 2. Figure 3 shows the responses of these parameters during phase I and 
phase II. In this patient a decrease in ECMO flow is associated with a decrease in 
SvO2 and SpO2 and an increase in HR and MAP. The effect is reversed when the 
flow is gradually increased back to baseline. Similar to the haemoglobin concen-
tration data, these systemic and ECMO circuit parameters do not return to their 
baseline values by the end of the monitoring period.  
 4 Discussion     
This single patient study showed significant changes in systemic oxygenation pa-
rameters and cerebral haemoglobin concentration in response to changes in 
ECMO flows. Reduction in flows was associated with a decrease in SvO2 and 
SpO2 and a significant increase in HHb but in the absence of a decrease in HbO2.  
A decrease in ECMO flow is associated with a decrease in oxygen delivery es-
pecially in the early course of ECMO treatment when the heart and lungs have not 
fully recovered. If ECMO flow is inadequate, there is a reduction in SvO2 and a 
subsequent decrease in SpO2. Consequently, in an effort to increase cardiac out-
put, there is a compensatory increase in HR. The decrease in SpO2 and SvO2 seen 
in this patient suggest that the lowering ECMO flows has a similar effect to a hy-
poxemic challenge and the absence of decrease in HbO2 in relation to increase in 
HHb could be explained by arterial dilation as a compensatory response to de-
creased blood flow due to decreased ECMO flows [7]. 
The changes seen in the total haemoglobin during this challenge in this patient 
are relatively large compared to the suggested total cerebral blood volume in an 
infant of 2.2mL/100g (50µM) [8]. Van Heijst et al. [2] report changes in HbO2 and 
HHb in the order of 1µmol/100g (10µM) 60 min after ECMO induction and sug-
gest no interhemispheric differences. EIjike et al. [3] report no relationship be-
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tween ECMO flow and tissue oxygen saturation but changes in the individual 
HbO2 and HHb parameters were not reported. 
 We noted significant differences between channel 10 and 8 which are difficult 
to explain and could be related to alterations in cerebral blood flow related to liga-
tion of the RCCA and IJV; however, we need further data to support this. In addi-
tion, regional variations in cerebral oxygenation could be related both to the pro-
cedure itself and to inhomogeneous differential pathlength factor [9]. The changes 
associated with ECMO flows did not return to baseline as the flow changes were 
reversed in the time period of the study. This might have been seen if we had ex-
tended the duration of the monitoring which we plan to do with further studies.  
5 Conclusions 
Multichannel optical topography can provide information on regional cerebral 
haemodynamics and oxygenation in ECMO patients. Simultaneous measurement 
of systemic and cerebral parameters can be used to characterise the response to 
changes in ECMO flows. In the patient studied here ECMO flows appear to 
present a significant haemodynamic challenge to cerebral circulation. ECMO flow 
changes may have the potential to inform on cerebral autoregulation but further 
studies are required to more fully explore the relationship between regional varia-
tions in cerebral oxygenation during different ECMO phases.  
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Table 1: Mean changes in HHb, HbO2 and HbT during phases I [between baseline flow (100%) 
and minimum flow (70%)] and II (between minimum flow and return to baseline ) 
Channel HHb (µM) HbO2 (µM) HbT (µM) 
I II I II I II 
1 11.2 -6.1 -2.9 7.0 8.3 1.0 
2 15.9 -6.5 -1.2 8.2 14.7 1.7 
3 15.2 -8.7 1.4 2.8 16.5 -5.9 
4 14.8 -4.7 3.8 9.2 18.6 4.5 
5 14.9 -10.8 -0.3 4.2 11.8 -6.6 
6 15.0 -9.2 1.9 4.8 14.6 -4.5 
7 16.2 -4.4 3.1 15.8 16.9 11.4 
8 25.1 -14.7 -2.8 3.7 19.4 -11.1 
9 16.1 -8.7 1.3 5.2 22.3 -3.5 
10 9.7 -10.8 -0.6 4.3 17.4 -6.5 
11 20.6 -10.7 -4.3 5.8 16.3 -5.0 
12 15.7 -11.0 0.5 9.2 16.2 -1.8 
Note: Bold letters indicate that changes are statistically significant (p<0.05)  
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Fig. 1 HbO2, HHb and HbT concentration changes from 12 channels during ECMO circuit flow 
changes. Each vertical line in the figures denotes where the ECMO circuit flow change occurred 
as annotated on channel 1 [a=baseline (100% flow), b=90% flow, c=80% flow, d=70% flow, 













Fig 3 Mean changes in systemic and ECMO parameters during phases I and II. 
 
 
 
